Taurolidine is an antibacterial and antifungal agent with a mechanism of action that is less prone to development of antimicrobial resistance. A taurolidine/heparin lock solution carries a lower risk ...

This is the first FDA-approved antimicrobial catheter lock solution. The FDA has approved taurolidine plus heparin (DefenCath®) catheter lock solution to reduce catheter-related bloodstream infections ...

January 26, 2011 — Substituting recombinant tissue plasminogen activator (rt-PA) for heparin once a week as a locking solution in the central venous catheters of patients receiving hemodialysis ...

The Food and Drug Administration (FDA) has approved DefenCath ® (taurolidine and heparin) catheter lock solution to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult ...

The CDC confirmed 14 cases of bloodstream infections in children across four U.S. states that may be connected to heparin and saline syringes distributed by medical technology company Becton Dickinson ...

Antimicrobial-containing citrate lock solutions are more effective than heparin lock solutions for the prevention of catheter-related bloodstream infections (CRBSIs), say researchers. In their ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — Neutrolin, an investigational new drug containing taurolidine, was shown to reduce catheter-related ...

To evaluate the effect of low-dose heparin on duration of peripherally inserted percutaneous central venous catheter (PCVC) patency and catheter occlusion. The main objective of this study was to ...